How long do you take progesterone pessaries after IVF?

How long do you take progesterone pessaries after IVF?

Luteal support with progesterone is necessary for successful implantation of the embryo following egg collection and embryo transfer in an in-vitro fertilization (IVF) cycle. Progesterone has been used for as little as 2 weeks and for as long as 12 weeks of gestation.

How long do you take Cyclogest after IVF?

Start using Cyclogest 400 mg on the day of egg retrieval. The administration of Cyclogest should be continued for 38 days if pregnancy has been confirmed.

How long should you lie down after progesterone pessary?

Remain lying down for around 30 minutes after insertion of the pessary. The best time to insert the pessary is at night before going to bed. Throw away any unused materials and wash your hands thoroughly. You may wish to wear a pantyliner for any minor discharge which may occur whilst using progesterone pessaries.

Do progesterone pessaries help implantation?

It will not have gone unnoticed by many of you that IVF patients in particular are being treated with progesterone vaginal pessaries as a means of enhancing the process of implantation. Progesterone is necessary for successful implantation of the embryo.

What does Cyclogest do in IVF?

Cyclogest pessaries are used to treat premenstrual syndrome, postnatal depression and help women having assisted reproductive treatment, such as IVF. Cyclogest pessaries contain the active ingredient progesterone, which is essential for normal functioning of the reproductive system.

How long after IVF pessary can I go to the toilet?

To aid absorption try to lay down for 20 minutes after inserting pessaries vaginally. If used rectally then you should not open your bowels for an hour after inserting the pessary, if you do then another dose is required.

Can Cyclogest affect my baby?

Cyclogest should not be used during pregnancy. There is limited and inconclusive data on the risk of congenital anomalies, including genital abnormalities in male or female infants, following intrauterine exposure during pregnancy.